King Gary, Gakidou Emmanuela, Imai Kosuke, Lakin Jason, Moore Ryan T, Nall Clayton, Ravishankar Nirmala, Vargas Manett, Téllez-Rojo Martha María, Avila Juan Eugenio Hernández, Avila Mauricio Hernández, Llamas Héctor Hernández
Institute for Quantitative Social Science, Harvard University, Cambridge, MA, USA.
Lancet. 2009 Apr 25;373(9673):1447-54. doi: 10.1016/S0140-6736(09)60239-7. Epub 2009 Apr 7.
We assessed aspects of Seguro Popular, a programme aimed to deliver health insurance, regular and preventive medical care, medicines, and health facilities to 50 million uninsured Mexicans.
We randomly assigned treatment within 74 matched pairs of health clusters-ie, health facility catchment areas-representing 118 569 households in seven Mexican states, and measured outcomes in a 2005 baseline survey (August, 2005, to September, 2005) and follow-up survey 10 months later (July, 2006, to August, 2006) in 50 pairs (n=32 515). The treatment consisted of encouragement to enrol in a health-insurance programme and upgraded medical facilities. Participant states also received funds to improve health facilities and to provide medications for services in treated clusters. We estimated intention to treat and complier average causal effects non-parametrically.
Intention-to-treat estimates indicated a 23% reduction from baseline in catastrophic expenditures (1.9% points; 95% CI 0.14-3.66). The effect in poor households was 3.0% points (0.46-5.54) and in experimental compliers was 6.5% points (1.65-11.28), 30% and 59% reductions, respectively. The intention-to-treat effect on health spending in poor households was 426 pesos (39-812), and the complier average causal effect was 915 pesos (147-1684). Contrary to expectations and previous observational research, we found no effects on medication spending, health outcomes, or utilisation.
Programme resources reached the poor. However, the programme did not show some other effects, possibly due to the short duration of treatment (10 months). Although Seguro Popular seems to be successful at this early stage, further experiments and follow-up studies, with longer assessment periods, are needed to ascertain the long-term effects of the programme.
我们评估了大众保险计划的相关方面,该计划旨在为5000万未参保的墨西哥人提供医疗保险、定期和预防性医疗服务、药品及医疗设施。
我们在74对匹配的卫生集群(即医疗设施服务区域)内进行随机分组,这些卫生集群代表墨西哥七个州的118569户家庭。在2005年基线调查(2005年8月至2005年9月)以及10个月后的随访调查(2006年7月至2006年8月)中,对50对(n = 32515)进行了结果测量。干预措施包括鼓励加入医疗保险计划以及升级医疗设施。参与项目的州还获得了资金,用于改善医疗设施并为干预集群中的服务提供药品。我们采用非参数方法估计意向性治疗效应和依从者平均因果效应。
意向性治疗估计显示,灾难性支出较基线水平降低了23%(1.9个百分点;95%置信区间0.14 - 3.66)。贫困家庭的效应为3.0个百分点(0.46 - 5.54),实验依从者的效应为6.5个百分点(1.65 - 11.28),分别降低了30%和59%。意向性治疗对贫困家庭医疗支出的效应为426比索(39 - 812),依从者平均因果效应为915比索(147 - 1684)。与预期及之前的观察性研究相反,我们发现对药品支出、健康结果或医疗服务利用没有影响。
项目资源惠及了贫困人口。然而,该项目未显示出其他一些效果,可能是由于治疗时间较短(10个月)。尽管大众保险计划在这个早期阶段似乎取得了成功,但需要进一步的实验和随访研究,并延长评估期,以确定该项目的长期效果。